Theophylline inhibits the release of eosinophil survival cytokines - Is Raf-1 the protein kinase A target?

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 3, 1998, Pages 47-52

  Shute, J K ^a   Tenor, H ^a   Church, M K ^a   Holgate, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; RAF PROTEIN; THEOPHYLLINE;

ARTICLE; ASTHMA; CYTOKINE PRODUCTION; DRUG ACTIVITY; ENZYME ACTIVATION; EOSINOPHIL; HUMAN; HUMAN CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

BRONCHODILATOR AGENTS; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INTERLEUKIN-8; MICROSPHERES; PHOSPHOLIPASES A; THEOPHYLLINE; TIME FACTORS;

EID: 0031902122     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal? Eur Resp J 1994; 7:579-91.
2. Banner KH, Page CP. Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors. Clin Exp Allergy 1996; 26 (S2):2-9.
3. Finnerty JP, Lee C, Wilson S et al. Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo- controlled parallel group study. Eur Resp J 1996; 9:1672-7.
4. Sullivan P, Bekir S, Jaffar Z et al. Anti-inflammatory effects of low dose oral theophylline in atopic asthma. Lancet 1994; 343:1006-8.
5. Gristwood RW, Llupia J, Fernandez AG, Berga P. Effect of theophylline compared with prednisolone on the late phase airway leukocyte infiltration in guinea pigs. Int Arch Appl Immunol 1991; 94:293-4.
6. Lagente V, Pruniaux M-P, Junien J-L, Moodley I. Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med 1995; 151:1720-4.
7. Kidney J, Dominguez M, Taylor PM et al. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151:1907-14.
8. Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 1996; 118:1727-35.
9. Sagara H, Kukuda T, Okada T, Ishikawa A, Makino S. Theophylline at therapeutic concentration suppresses PAF-induced upregulation of Mac-1 on human eosinophils. Clin Exp Allergy 1996; 26 (S2):16-21.
10. Woolley KL, Gibson PG, Carty K et al. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154:237-43.
11. Ohta K, Sawamoto S, Nakajima M et al. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 1996; 26 (S2):10-5.
12. Park H-S, Jung K-S, Shute JK et al. Allergen- induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival. Eur Resp J 1997; in press:.
13. Levi-Schaffer F, Lacy P, Severs NJ et al. Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 1995; 85:2579-86.
14. Yousefi S, Hemmann S, Weber M et al. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 1995; 154:5481-90.
15. Hansel TT, De Vries IJM, Iff T et al. An improved immunomagnetic procedure for isolation of eosinophils. J Immunol Meth 1991; 145:105-10.
16. Mikako I, Weiler D, Kita H, Gleich GJ. Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. J Immunol Meth 1994; 168:187-96.
17. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989; 142:2393-400.
18. Shute JK, Vrugt B, Lindley IJD et al. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997; 155:1877-83.
19. Nakajima H, Gleich GJ, Kita H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 1996; 156:4859-66.
20. Monteiro RC, Hostoffer RW, Cooper MD et al. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993; 92:1681-5.
21. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT. Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. J Immunol 1991; 146:2712-8.
22. Miyamasu M, Hirai K, Takahashi Y et al. Chemotactic agonists induce cytokine generation in eosinophils. J Immunol 1995; 154:1339-49.
23. Ebisawa M, Schleimer RP, Iikura Y et al. Phenotypic analysis of purified human eosinophils using a panel of 473 monoclonal antibodies: comparison to neutrophil phenotype. J Allergy Clin Immunol 1994; 93:213.
24. Kanayama N, Kajiwara Y, Goto J et al. Inactivation of interleukin-8 by aminopeptidase N (CD 13). J Leukoc Biol 1995; 57:129-34.
25. Padrines M, Wolf M, Walz A, Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Letts 1994; 352:231-5.
26. Matsunaga Y, Kido H, Kawaji K et al. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils. Arch Biochem Biophys 1994; 312:67-74.
27. Hatzelmann A, Tenor H, Schudt C. Differential effects of non-selective and selective phosphodiesterase inhibitors on eosinophil functions. Br J Pharmacol 1995; 114:821-31.
28. Resnick MB, Colgan SP, Patapoff TW et al. Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5′-AMP. J Immunol 1993; 151:5716-23.
29. Bergstrand H. Phosphodiesterase inhibition and theophylline. Eur J Respir Dis 1980, 61 (S; 109):37-44.
30. Lewis RA, Devens B, Fong A, Wilhelm RS. The therapeutic potential of PDE4 inhibitors in asthma. In: Chanez P, Bousquet J, Michel FB, Godard P, eds From Genetics to Quality of Life. Hogrefe and Huber, 1996:166-74.
31. Kelley TJ, Al-Nakkash L, Drumm ML. CFTR-mediated chloride permeability is regulated by type III phosphodiesterases in airway epithelial cells. Am J Respir Cell Mol Biol 1995; 13:657-64.
32. Skalhegg BS, Tasken K, Hansson V et al. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science 1994; 263:84-7.
33. Aloui R, Gormand F, Prigent AF, Perrin-Fayolle M, Pacheco Y. Increased respiratory burst and phosphodiesterase activity in alveolar eosinophils in chronic eosinophilic pneumonia. Eur Resp J 1996; 9:377-9.
34. Linden A. Increased interleukin-8 release by β-adrenoreceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol 1996; 119:402-6.
35. Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989; 143:1366-71.
36. Van der Bruggen T, Koenderman L. Signal transduction in eosinophils. Clin Exp Allergy 1996; 26:880-91.
37. Kato M, Abraham RT, Kita H. Tyrosine phosphorylation is required for eosinophil degranulation induced by immobilised immunoglobulins. J Immunol 1995; 155:357-66.
38. Bokoch GM. Chemoattractant signalling and leukocyte activation. Blood 1995; 86:1649-60.
39. 2. J Clin Invest 1993; 91:2118-25.
40. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268:14553-6.
41. Nahas N, Molski TFP, Fernandez GA, Sha'afi RI. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP) -kinase cascade in human neutrophils stimulated with various agonists. Biochem J 1996; 318:247-53.
42. Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R. The intracellular signal transduction mechanism of interleukin-5 in eosinophils: The involvement of Lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 1995; 181:1827-34.
43. Pazdrak K, Pazdrak B, Garofalo R, Alam R. The IL-5 signaling through Jak-2, Lyn and Raf-1 kinases is essential for eosinophil viability whereas Raf-1 is also required for priming and activation of eosinophils. J Allergy Clin Immunol 1997:S135.
44. Marx J. Two major signal pathways linked. Sci 1993; 262:988-90.
45. Mischak H, Seitz T, Janosch P et al. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol Cell Biol 1996; 16:5409-18.
46. Schudt C, Tenor H, Hatzelmann A. PDE isoenzymes as targets for anti-asthma drugs. Eur Respir J 1995; 8:1179-83.